Veltex(OTC) VLXC

Market Cap$4.46M

Since IPO (1991)-100%

5 Year-95%

1 Year-45%

1 Month+10%

$0.04

+0.00%

+0.00Today

Veltex last closing stock price
Metric	Price	Date
Last close	USD 0.04	2026-09-24

Veltex stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.04	2026-09-17
1 month	+10%	USD 0.04	2026-08-21
3 month	+46.67%	USD 0.03	2026-06-26
Year to date	-36.23%	USD 0.07	2025-12-29
1 year	-45%	USD 0.08	2025-09-24
3 year	-74.83%	USD 0.17	2023-09-22
5 year	-94.76%	USD 0.84	2021-09-24
Since inception	-100%	USD 27,777.78	1991-01-02

Veltex Financials at a Glance

Market Cap

$4.46M

Revenue (TTM)

$1.52M

Net Income (TTM)

-$1.64M

EPS (TTM)

-$0.02

P/E Ratio

-2.63

Dividend

$0.00

Beta (Volatility)

0.29 (Low)

Dividend

$0.00

Beta (Volatility)

0.29 (Low)

Price

$0.04

Volume

Open

$0.04

Price

$0.04

Volume

Open

$0.04

Previous Close

$0.04

Daily Range

$0.04 - $0.04

52-Week Range

$0.03 - $0.08

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

0.29 (Low)

Price

$0.04

Volume

Open

$0.04

Previous Close

$0.04

Daily Range

$0.04 - $0.04

52-Week Range

$0.03 - $0.08

Estimated Earnings Date

N/A

VLXC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Veltex

Veltex Corporation is focused on creating and acquiring businesses that deliver solutions in the health, wellness, and recovery sectors. Established in 1987 and headquartered in Chicago, Illinois, the company primarily serves rehabilitation and treatment centers.

Products and Services

Health and wellness solutions for rehabilitation centers
Acquisition of businesses in the healthcare sector
Innovative recovery programs and services

Growth Outlook

Recent quarterly revenue of $290,159 shows potential for recovery
Gross profit margin improved to 89.5% in Q1 2026
Focus on expanding service offerings in the healthcare market

Financial Highlights

Trailing twelve months (TTM) revenue of $1,694,000 indicates steady performance
Net income for Q1 2026 was -$474,261, reflecting ongoing challenges
Current ratio of 0.21 suggests liquidity concerns

Veltex Corporation operates in the healthcare sector, specifically targeting the rehabilitation and treatment markets. The company has shown resilience with a recent quarterly revenue of $290,159, indicating a potential turnaround. The gross profit margin of 89.5% in Q1 2026 highlights the efficiency of its operations, despite facing challenges reflected in the net income of -$474,261. The trailing twelve months revenue of $1,694,000 suggests a consistent demand for its services, while the current ratio of 0.21 raises concerns about liquidity. The focus on expanding service offerings positions Veltex Corporation for future growth in the healthcare market, making it an intriguing option for investors interested in the medical care facilities industry.

AI Generated • Sep 4, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

CEO

Andreas Mauritzson

Website

www.veltex.com

Headquarters

Chicago, IL 60602, US

VLXC Financials

Key Financial Metrics (TTM)

Gross Margin

67.11%

Operating Margin

-86.73%

Net Income Margin

-108.02%

Return on Equity

56.80%

Return on Capital

-453.08%

Return on Assets

-90.28%

Earnings Yield

-38.02%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.46M

Shares Outstanding

101.37M

Volume

Avg. Volume

3.12K

Financials (TTM)

Gross Profit

$1.02M

Operating Income

-$1.32M

EBITDA

-$1.15M

Operating Cash Flow

-$683.88K

Capital Expenditure

-$5.00

Free Cash Flow

-$683.88K

Cash & ST Invst.

$5.77K

Total Debt

$3.58M

Veltex Performance Analysis

Veltex annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 30,810	692.4%
2023	2023-12-31	USD 838,654	2622.0%
2024	2024-12-31	USD 1,381,258	64.7%
2025	2025-12-31	USD 1,905,185	37.9%

Veltex sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	10.4%
Q4	2025-12-31	-17.9%
Q1	2026-03-31	-29.9%
Q2	2026-06-30	7.1%

Veltex annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -0.05	18.5%
2023	2023-12-31	USD -0.01	-73.9%
2024	2024-12-31	USD -0.01	-9.3%
2025	2025-12-31	USD -0.01	13.7%

Veltex sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	29.6%
Q4	2025-12-31	-278.9%
Q1	2026-03-31	33.3%
Q2	2026-06-30	41.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$310.81K

-31.9%

Gross Profit

$280.39K

-35.6%

Gross Margin

90.21%

N/A

Market Cap

$4.46M

N/A

Market Cap/Employee

$3.72K

N/A

Employees

1,200

N/A

Net Income

-$277.89K

-13.5%

EBITDA

-$112.65K

-10.0%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$5.77K

-78.5%

Total Debt

$3.58M

+23.6%

Accounts Receivable

$959.63K

+5.9%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$3.58M

+23.6%

Return on Assets

-90.28%

N/A

Return on Invested Capital

41.50%

N/A

Free Cash Flow

-$123.99K

-31.3%

Operating Cash Flow

-$123.99K

-39.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BVAXFBioVaxys Technology Corp.

BVAXFBioVaxys Technology Corp.$0.13+54.39%

PMEDFQscreen Ai Inc.

PMEDFQscreen Ai Inc.$0.02+0.00%

BICXBioCorRx Inc.

BICXBioCorRx Inc.$0.20-5.19%

ADMTADM Tronics Unlimited, Inc.

ADMTADM Tronics Unlimited, Inc.$0.05+0.00%

VYCOVycor Medical, Inc.

VYCOVycor Medical, Inc.$0.07+0.00%

BZYRBurzynski Research Institute, Inc.

BZYRBurzynski Research Institute, Inc.$0.00+0.00%

TWSITristar Wellness Solutions Inc.

TWSITristar Wellness Solutions Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NKENike

NKENike$33.87-3.64%

NVDANvidia

NVDANvidia$233.95+1.34%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$158.96+7.36%

SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF

SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF$29.71-6.46%

INTCIntel

INTCIntel$119.33-0.56%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$11.28-0.44%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.80+9.25%

Questions About VLXC

What is the current price of Veltex?

Veltex is trading at $0.04 per share.

What is the 52-week range for Veltex?

Over the past 52 weeks, Veltex has traded between $0.03 and $0.08.

How much debt does Veltex have?

As of the most recent reporting period, Veltex reported total debt of $3.58M.

How much cash does Veltex have on hand?

Veltex reported $5.77K in cash and cash equivalents in its most recent financial results.

What is Veltex’s dividend yield?

Veltex does not currently have a dividend yield.

Veltex(OTC) VLXC

Veltex Financials at a Glance

VLXC News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Veltex

VLXC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Veltex Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VLXC

What is the current price of Veltex?

What is the 52-week range for Veltex?

How much debt does Veltex have?

How much cash does Veltex have on hand?

What is Veltex’s dividend yield?

Premium Investing Services